SHANNON LEE: Open Payments
NPI 1568851491 · HARTSELLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 28 payments from 13 companies in 2025. Trend: 2023 $899 · 2024 $1,249 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| GENZYME CORPORATION | 1 | $35 |
| Exact Sciences Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
Products named: TEZSPIRE, AIRSUPRA, DUPIXENT, CAPLYTA, BREZTRI, TRELEGY ELLIPTA, Cologuard Collection Kit, JARDIANCE.
Industry payments across AL — which companies pay providers there.
